Assesses adolescent females 16–20 years of age who were screened unnecessarily for cervical cancer.
Note: A lower rate indicates better performance.
Why It Matters
Cervical cancer screening can result in more harm than benefits for adolescent females. Adolescent females tend to have high rates of transient HPV infection and regressive cervical abnormalities. This may produce false-positive results and lead to unnecessary and potentially detrimental follow-up tests and treatment.¹
Results – National Averages
Non-Recommended Cervical Cancer Screening in Adolescent Females*
| Measure Year | Commercial HMO | Commercial PPO | Medicaid HMO |
|---|---|---|---|
| 2022 | 0.5 | 0.5 | 0.5 |
| 2021 | 0.6 | 0.6 | 0.6 |
| 2020 | 0.7 | 0.7 | 0.7 |
| 2019 | 0.9 | 0.9 | 0.8 |
| 2018 | 1.1 | 1.1 | 1 |
| 2017 | 1.5 | 1.5 | 1.5 |
| 2016 | 1.8 | 1.9 | 2 |
| 2015 | 2.3 | 2.4 | 2.7 |
| 2014 | 3.4 | 3.8 | 3.8 |
This State of Healthcare Quality Report classifies health plans differently than NCQA’s Quality Compass. HMO corresponds to All LOBs (excluding PPO and EPO) within Quality Compass. PPO corresponds to PPO and EPO within Quality Compass.
Figures do not account for changes in the underlying measure that could break trending. Contact Information Products via my.ncqa.org for analysis that accounts for trend breaks.
References
- Kulasingam, S.L, L. Havrilesky, R. Ghebre, E.R Myers. 2011. “Screening for Cervical Cancer: A Decision Analysis for the U.S. Preventive Services Task Force.” Agency for Healthcare Research and Quality. Report No.: 11-05157-EF-1. Rockville, MD